Once considered a rarity, infectious microorganisms are associated with at least 20% of all cancers, according to Denise Galloway of the Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, Wash. She and other investigators presented fındings that bolster the view that microbes play an important role for many types of cancer during the plenary session "Malignant Microbiology" at the 2014 ASM General Meeting in Boston last May.
Because only a small fraction of those infected with Helicobacter pylori develop gastric adenocarcinoma, additional factors likely also contribute to this type of cancer, according to Karen Guillemin of the University of Oregon, Eugene. The H. pylori virulence factor CagA, which these bacteria inject into stomach cells, promotes this disease, she says. Moreover, intestinal cells in CagA-expressing zebrafısh proliferate abnormally, and, in fısh that no longer make tumor suppressor p53, intestinal cancer develops. A commensal Aeromonas bacterium in zebrafısh produces a protein that leads epithelial cells to proliferate, she says, adding. "We were able to identify and clone this protein, and we determined the sequence." Based on that information, she and her collaborators found homologous genes in bacteria from the human gut. One such homolog from Vibrio cholerae is pro-proliferative in zebrafısh, she says.
Zebrafısh bearing a mutation in the host gene axin1, a gene commonly mutated in human colorectal cancers, ex-hibit greater intestinal hyperplasia when colonized exclusively with this pro-proliferative Aeromonas than when reared germ-free or with other gut microbes, "indicating the importance of the microbial context for the oncogenic impact of different genetic mutations," Guillemin says.
Collectively, these results suggest that the gut microbiome could either protect against or accelerate cancer. "Researchers or clinicians might want to profıle the gut microbiota of patients for their pro-proliferative capacity, and to consider using probiotic therapy to modify the gut microbiota in order to reduce pro-proliferative activity," she says.
Viruses also are involved in carcinogenesis, according to Galloway of FHCRC. For example, a polyomavirus causes Merkel cell carcinoma, a rare but highly malignant and metastatic skin cancer that is seen most among elderly or immunosuppressed individuals. Merkel cells are epithelial touch receptors that have neuroendocrine features.
Antibodies to a portion of the T antigen, which drives the tumor, are found only in patients with the cancer and, if those antibodies drop following treatment, and remain low, "it means the patient is disease free," Galloway says. "But if they go up again, it means the patient will have a recurrence. Once you know someone may have a recurrence, you can get them in and do scans, and treat metastases."
Because intravenously injected bac-teria can penetrate tissues without causing side effects, they offer a potential advantage over conventional chemotherapy as a means for treating tumors, according to Neil S. Forbes of the University of Massachusetts, Amherst. He and his collaborators began with an attenuated salmonella strain, and then modifıed it to carry one of several genes to kill cancer cells, including a gene encoding a mammalian protein that induces programmed cell death and another encoding a pore-forming protein, Forbes says. When injected into mice, these attenuated strains expressed those proteins, which caused tumor regression and increased survival, and the bacterial cells stayed within the tumor, he says.
David C. Holzman is the Microbe Journal Highlights Editor.
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Skepticism, Curiosity Helped To Overcome Microbiological Dogmas
Jeffrey L. Fox "Dogmas die dismal deaths," declared the delighted docents who described disparate examples of this phenomenon from recent microbiological research efforts during the symposium "Dispelling Dogmas" at the 2014 ASM General Meeting in Boston last May. Not to be too dismal, but disposing of scientifıc dogmas proves to be a serious challenge and sometimes resembles the game of whack-a-mole: putting an end to one doctrine is in danger of leading to establishing others in its stead.
When it comes to assessing various bacteria and viruses that associate with humans or other host species, Didier Raoult of Aix-Marseille University in Marseille, France, describes how he and his collaborators are overturning dogmas across several microbial dimensions. About a decade ago, for instance, he announced that Mycobacterium tuberculosis grows unexpectedly rapidly on blood agar plates incubated under microaerophilic conditions. "People hated that because it was too simple," he says. However, a big advantage to this break from other ways of growing these fastidious pathogens is that drug susceptibility tests can be completed within 48 hours, faster than by other means, he points out.
Switching gears to describe his involvement in microbiota research, Raoult says, "Of course, we're doing metagenomics like mad. But you need to culture." Thanks to a reliance on nonconventional "culturomics," which entails trying to grow anything and every microorganism in a sample under highly permissive conditions, his group has identifıed some 75 "new species" from the human gut, he says. "We are beating the rest of the world in getting new species with this approach, [including] archaea. There are plenty in humans and also plenty of new fungi, but few groups are looking for them."
Perhaps the downfall of the central virus dogma counts as Raoult's principal claim to fame when it comes to overturning settled doctrines. "The dogma is that a virus is small, but this was stupid," he says. Much earlier, viruses were defıned in part as particles small enough to pass through a certain pore size of a fılter. From that time until recently when he and his collaborators began to fınd far-larger viral particles, others simply discarded the specimens that did not pass through the pores because dogma dictated that there were no large-scale viruses to be found, he exclaims, with considerable relish.
"What does immunoglobulin A (IgA) do?" asks Gerald Pier of Harvard Medical School in Boston, Mass., who cochaired this symposium. Although IgA is considered critical for mucosal immunity, that well-established belief might instead be "immunomythology," he says. IgA is "the most common primary immunodefıciency" but individuals who are missing it are "asymptomatic" and their numbers are "underestimated." Both IgG and IgM antibodies can compensate for missing IgA, he says. However, it does appear to be important for preventing transmission of some pathogens at the local and mucosal level, he adds. "I'm not trying to trash the whole fıeld of mucosal immunology. Maybe IgA is essential for other species, and maybe humans are going through an evolutionary loss of this system."
In yet another example of dogmas in flux, Geobacter sulfurreducens, a bacterial species that can transmit electrons, conducts that electricity along aromatic amino acids within the proteins
MINITOPIC
Progress in Growing, Analyzing Difficult-to-Culture Microbes
A microfluidic device, called a Slip-Chip, enables individual microbial cells to grow separately but close to one another, after which the device can be split in half to analyze a portion of any sought-after, but difficult-to-culture microbial species while preserving another portion for further growth and analysis, 
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Gut Microbes Join Host in Metabolizing, Perhaps Detoxifying Arsenic
Carol Potera
The gut microbiome helps to convert inorganic arsenic into organic metabo-lites in at least two different ways. Sulfur-reducing bacteria in the colon play an important role in attaching arsenic to sulfur-containing metabolites through thiolation reactions, according to Sergio Rubin, Tom Van de Wiele, and their colleagues at the University of Gent in Belgium. Moreover, according to Kun Lu and his collaborators at the University of Georgia, Athens (UGA), infecting mice with Helicobacter trogontum increases the arsenic metabolites that such animals excrete in their urine.
Residues containing inorganic arsenic are consumed as foods and in water, and then are converted into organic metabolites such as monomethylarsonic acid (MMA) and subse-quently, via hydrogen sulfıde, monomethyl monothioarsonic acid (MMMTA). Scientists long assumed that the liver is the host site where these metabolic changes occur.
However, the metabolic fate of inorganic arsenic apparently depends on the gut microbiota, according to Rubin and his collaborators at the University of Gent. Instead of the liver, Desulfovibrio desulfuricans piger bacteria in the gut, which are a major source of hydrogen sulfıde, are needed for converting MMA into MMMTA, he says. In experiments in culture, microbially generated hydrogen sulfıde also drives steps that further modify these arseniccontaining metabolites. Details appeared 9 May 2014 in Environmental Health Perspectives (doi:10.1289/ehp .1307759).
Other lines of evidence implicate D. desulfuricans piger and its capacity to generate hydrogen sulfıde in arsenic metabolism. For example, adding molybdate, which stops ATP-sulfurylase from generating hydrogen sulfıde, to cultured D. desulfuricans piger reduces how much MMA can be converted to MMMTA. Separately, Rubin and his collaborators collected and analyzed human fecal samples for their capacity to generate hydrogen sulfıde-another measure of D. desulfuricans piger activity. Those samples that generate more hydrogen sulfıde are better at converting MMA into MMMTA, the researchers report.
Ingesting arsenic raises the risk for cancer, diabetes, and cardiovascular disease. However, organic metabolites such as MMA generally are less toxic than is inorganic arsenic, whereas some thiolated metabolites of arsenic are more cytotoxic than are their sulfur-free counterparts. "We need more information about the microbial ecology of sulfur-reducing bacteria to assess their role in arsenic toxicity," says Rubin.
"The bacterial composition of the human gut varies and could be a risk factor for arsenic toxicity," says Lu of
MINITOPIC
Update: Microbiology at the Federal Level-Drug Resistance, Safety and Cost Issues, New Antibacterial
Recent interest and attentions from top federal officials and Congress to microbial issues include:
• During the July 2014 meeting of the President's Council of Advisors on Science and Technology (PCAST), council members focused on antibiotic resistance, previewed its upcoming report on this subject, endorsed efforts by the Food and Drug Administration (FDA) to deal with antibiotic uses in meat and poultry production, and recommended establishing an interagency task force devoted to this issue. • Thomas Friedman, Director of the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., in July issued a report and also shut down several laboratories at CDC following incidents in which personnel were inadvertently exposed to anthrax and, separately, samples containing H5N1 influenza were mistakenly distributed by CDC to another federal agency. • Vials containing the smallpox virus were moved to CDC in July following their discovery in a storage room of the FDA on the campus of the National Institutes of Health (NIH) in Bethesda, Md. After tests for viability are completed, the material is set to be destroyed, subject to terms of an international agreement permitting that live smallpox samples be held in only two repositories, one at CDC and the other in Russia. • Senators Ron Wyden (D-OR) and Charles Grassley (R-IA) sought detailed pricing information for Sovaldi, a drug to treat hepatitis C infections, from Gilead Sciences of Foster City, Calif., the company that developed and is now marketing that drug. Together, these studies suggest that "the gut microbiota can extensively metabolize arsenic prior to intestinal absorption," says Kathryn Ramsey at the Telethon Institute for Child Health Research in Subiaco, Australia. Individual differences in arsenic metabolism, including those stemming from differences in microbiota, could contribute to variability of arsenic toxicity, she says.
Carol Potera is a freelance writer in Great Falls, Mont.
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Farm to Table: Predicting, Preventing Foodborne Outbreaks Shannon Weiman
Monitoring pathogens for their infectious capacity in humans may not be the best approach to minimize the risk of foodborne outbreaks, say researchers who spoke during the 2014 ASM General Meeting in Boston last May. Other factors come into play-particularly, the ability of some pathogens to colonize food sources, proliferate, and thus amplify the inoculating dose delivered to consumers is critically important, they say. Colonizing food sources also can alter gene expression, increasing pathogenicity and decreasing the infectious dose. Understanding this "ecology" could prove crucial for predicting and preventing foodborne outbreaks.
Produce is the leading source of foodborne illness commonly caused by Salmonella enterica or Escherichia coli O157:H7 on leafy greens, according to Maria Brandl of the U.S. Department of Agriculture (USDA) in Albany, Calif. "The continuous rise in the number of outbreaks of foodborne illness linked to fresh fruit and vegetables challenges the notion that enteric pathogens are defıned mostly by their ability to colonize the intestinal habitat," she says. "Enteric pathogens utilize diverse and overlapping strategies to interact with plants and their microflora, and to successfully colonize vertebrate hosts."
Because plant surfaces and tissues are subject to fluctuating temperatures, exposure to ultraviolet light, and are not so rich in nutrients, they were considered inhospitable to enteric microbes in the past. However, damage by plant pathogens or during processing makes this environment resemble what enteric pathogens encounter in the mammalian gut, promoting their growth. For example, the plant pathogen Dickey didantii breaks down plant tissues, releasing nutrients and creating anaerobic conditions in which S. enterica thrives, according to Brandl. Similar changes arise when greens are being cut and processed as foods, and those changes support E. coli growth, increasing its proliferation more than fıvefold, she says.
"Genes induced in soft rot lesions are also involved in the colonization of mouse, pig, and bovine models of host infection," Brandl continues. Within macerated plant tissues, enteric pathogens upregulate genes for nutrient uptake and anaerobic metabolism, preparing them for the conditions that they will encounter within the intestines of animals and humans who also break down those plant materials during digestion. In addition, virulence genes are induced in the damaged tissue of fresh-cut greens , which may also increase the pathogenicity of the enteric bacteria that contaminate such plant tissues. Meanwhile, upregulation of stress response genes provides the bacterial pathogens with resistance to chlorine sanitizers and antimicrobials as well as potentially better means to withstand oxidative immune responses from those who eat the plants. When enteric pathogens adapt to animal hosts, their pathogenicity against humans may be enhanced even further, according to Victor Gannon of the Public Health Agency of Canada in Lethbridge, Alberta. For example, particular human disease-associated lineages of E. coli express higher levels of Shiga toxin, which may provide these bacteria with a selective advantage when growing in cattle without harming that host, but inadvertently increases the pathogenicity of these bacteria within humans, he says. The open-source bioinformatics platform, called SuperPhy, that he and his collaborators developed includes algorithms to help identify bacterial subpopulations of clinical importance. "Group-and sub-group-specifıc core genes are thought to contribute to shared phenotypes such as virulence and niche specifıcity," he says. He is applying this approach to determine which livestock hosts generate the most pathogenic strains of Campylobacter jejuni, another bacterial source of foodborne gastroenteritis.
Shannon Weiman is a freelance writer in San Francisco, Calif.
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Deep-Sea Viruses Implicated in Global Sulfur Cycle Barry E. DiGregorio
Abundant, double-stranded DNA marine viruses carry genes encoding en-zymes that appear to be part of the metabolic complex used by sulfur-oxidizing bacteria of the SUP05 clade, according to Karthik Anantharaman and Gregory J. Dick of the University of Michigan, Ann Arbor, and their collaborators there and at other U.S. institutions. Their fındings implicate viruses as "a key agent" in the global sulfur cycle and also as "a reservoir of genetic diversity for bacterial enzymes" underpinning chemosynthesis in the oceans. Details appeared 16 May 2014 in Science (doi:10.1126/science. 1252229).
Samples of sea water from fıve hydrothermal plumes in the Eastern Lau Spreading Center (Lau Basin) in the western Pacifıc Ocean and one plume at Guaymas Basin in the Gulf of California were subjected to shotgun sequencing analysis for bacterial and viral DNA signatures, according to Dick and his collaborators. "The viruses carry genes involved in the oxidation of elemental sulfur, which is an intermediate of sulfur oxidation that is stored intracellularly by many chemolithotrophic bacteria," he says. "We suggest that the viral genes may enhance the bacterial oxidation of this elemental sulfur."
Although marine viruses easily outnumber their host bacteria, the two populations maintain a balance, even if no one knows precisely how, Dick continues. "Certainly part of the answer is that bacteria and archaea have defenses against viruses, some of which can be acquired and specifıcally target certain viruses and provide immunity to them," he says. "So while certain genotypes may very well be eliminated, other closely related genotypes would become immune and fıll the niche."
Because deep-sea chemolithotrophic bacteria such as SUP05 cannot yet be grown in culture, Dick and his collaborators focused their metagenomic analyses on the viruses that infect such bacteria. The viral genomes are highly conserved across hydrothermal vent environments and ocean basins, and all
MINITOPIC
Recently Observed, Unusual and Notable Microbial Behaviors or Traits
Recently described examples of unusual microbial behaviors or traits include:
• Bacteria living beneath the floor of the sea cope with the stresses of this environment in part by overactivating stress response and DNA-repair mechanisms, according to the rdsrA sulfur-oxidizing genes that they contain are also affıliated with those found in SUP05 bacteria. These viruses are involved in the biogeochemical sulfur cycle, and they could be influencing it in ways that differ than if those activities were being conducted only by SUP05 or similar sulfur-oxidizing bacteria, according to Dick. For instance, the enzymes encoded by the viruses may help to decrease the elemental sulfur stored within bacterial cells, he says, adding: "We believe that . . . viruses are enhancing sulfur oxidation by the bacterial host in order to increase resources available for viral reproduction, but this still needs to be tested experimentally."
These fındings are "a major advance in our understanding of the roles of viruses in deep sea chemolithotrophic processes, and sulfur oxidation in particular," says Jed Fuhrman at the University of Southern California, Los Angeles. "It is impressive how they used the latest tools of genomic assembly from metagenomes to generate numerous viral genomes. We can now add sulfur oxidation to the list of 'bacterial' processes supported by virus-encoded genes. This report also provides strong evidence for horizontal gene transfer between SUP05 bacteria and viruses." Barry E. DiGregorio is a freelance writer in Middleport, N.Y.
NEW IN ASM JOURNALS
New Model Very Promising for Study of Virus-Host Interaction
Orsay virus, recently discovered in a wild Caenorhabditis elegans strain, is the only known virus capable of naturally infecting this model organism. As many fundamental biological discoveries have been made in C. elegans, Orsay virus's ability to infect it provides a unique, powerful system to defıne multiple aspects of host-virus interactions. Now Hongbing Jiang, Carl J. Franz, and David Wang of Washington University, St. Louis, Mo., have developed a reverse genetic system for creating mutant forms of Orsay virus, which Wang says "will enable us to fully capitalize upon this system," he says. Wang anticipates new opportunities to better understand how hosts deal with virus infection and how viruses exploit the host.
